Subgroup-analysis of patients receiving APT within 24 hours after rt-PA thrombolysis in the first European Cooperative Acute Stroke Study (ECASS-I) showed a slight trend towards increased mortality from all causes (including SICH).
← all excerpts
A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.
1
—
—